Shu Dong Zhang
Overview
Explore the profile of Shu Dong Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Zhang F, Yan Y, Cao C, Li C, Deng S, et al.
Beijing Da Xue Xue Bao Yi Xue Ban
. 2023 Oct;
55(5):843-850.
PMID: 37807738
Objective: To investigate the imaging effect of a near-infrared fluorescent targeted probe ICG-NP41 on the neurovascular bundles (NVB) around the prostate in rats. Methods: A near-infrared fluorescent targeted probe ICG-NP41...
2.
[Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus]
Lan D, Liu Z, Li Y, Wang G, Tian X, Ma L, et al.
Beijing Da Xue Xue Bao Yi Xue Ban
. 2023 Oct;
55(5):825-832.
PMID: 37807735
Objective: To investigate and analyze the risk factors of massive hemorrhage in patients with renal cell carcinoma and venous tumor thrombus undergoing radical nephrectomy and removal of venous tumor thrombus....
3.
Mao H, Zhang F, Zhang Z, Yan Y, Hao Y, Huang Y, et al.
Beijing Da Xue Xue Bao Yi Xue Ban
. 2023 Oct;
55(5):818-824.
PMID: 37807734
Objective: Constructing a predictive model for urinary incontinence after laparoscopic radical prostatectomy (LRP) based on prostatic gland related MRI parameters. Methods: In this study, 202 cases were included. All the...
4.
Xue Z, Tang S, Qiu M, Liu C, Tian X, Lu M, et al.
Beijing Da Xue Xue Bao Yi Xue Ban
. 2023 Oct;
55(5):802-811.
PMID: 37807732
Objective: To retrospectively analyze clinical data of patients under 40 years old who underwent surgical treatment for renal tumors with tumor thrombus from January 2016 to December 2022 at Peking...
5.
Wong J, Wei R, Lyu P, Tong O, Zhang S, Wen Q, et al.
Int J Biol Sci
. 2017 Dec;
13(11):1373-1386.
PMID: 29209142
Osteopontin (OPN) plays an important role in cancer progression, however its prognostic significance and its downstream factors are largely elusive. In this study, we have shown that expression of OPN...
6.
Mahadevappa R, Neves H, Yuen S, Bai Y, McCrudden C, Yuen H, et al.
Sci Rep
. 2017 Apr;
7(1):985.
PMID: 28428557
DNA replication is a critical step in cell proliferation. Overexpression of MCM2-7 genes correlated with poor prognosis in breast cancer patients. However, the roles of Cdc6 and Cdt1, which work...
7.
Li B, McCrudden C, Yuen H, Xi X, Lyu P, Chan K, et al.
Oncotarget
. 2017 Jan;
8(7):11144-11159.
PMID: 28055976
CD133 has been shown to be an important stem cell factor that promotes glioma progression. However, the mechanism for CD133-mediated glioma progression has yet to be fully elucidated. In this...
8.
Ye Z, Al-Aidaroos A, Park J, Yuen H, Zhang S, Gupta A, et al.
Sci Rep
. 2015 Nov;
5:17046.
PMID: 26597054
PRL-3, a metastasis-associated phosphatase, is known to exert its oncogenic functions through activation of PI3K/Akt, which is a key regulator of the rapamycin-sensitive mTOR complex 1 (mTORC1), but a coherent...
9.
Park J, Yuen H, Zhou J, Al-Aidaroos A, Guo K, Valk P, et al.
EMBO Mol Med
. 2013 Aug;
5(9):1351-66.
PMID: 23929599
FLT3-ITD mutations are prevalent mutations in acute myeloid leukaemia (AML). PRL-3, a metastasis-associated phosphatase, is a downstream target of FLT3-ITD. This study investigates the regulation and function of PRL-3 in...
10.
Al-Aidaroos A, Yuen H, Guo K, Zhang S, Chung T, Chng W, et al.
J Clin Invest
. 2013 Jul;
123(8):3459-71.
PMID: 23867504
Metastasis-associated phosphatase of regenerating liver-3 (PRL-3) has pleiotropic effects in driving cancer progression, yet the signaling mechanisms of PRL-3 are still not fully understood. Here, we provide evidence for PRL-3-induced...